Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
59:31
Anticoagulants in Older Adults
1:00:08
Women’s Health Considerations in Thrombosis Webinar
56:26
Navigating the 2024 PAD Guidelines
1:01:21
HOT TOPICS - ANNEXA-I Trial
32:51
Reversing oral anticoagulants with a focus on Andexanet Alfa
1:26:47
Advances in VHL Disease: Insights from Recent Research with Othon Iliopoulos, MD, PhD | Nov 2024
1:05:44
WSA Webinar - Management of stroke in the new era of oral anticoagulation
10:32